Table 1 Baseline clinical characteristics of chronological age groups
Variables | Overall Population (n = 8163) | <60 years (n = 5691) | ≥60 years (n = 2472) | P Value |
|---|---|---|---|---|
Chronological age, year | 55.0 (50.5–61.0) | 53.0 (49.0–56.0) | 66.0 (62.0–72.0) | <0.001 |
Vascular age, year | 55.6 (52.2–60.4) | 53.8 (51.1–57.0) | 61.8 (57.7–66.3) | <0.001 |
∆-age, year | −0.26 (−3.0 to 2.8) | −0.36 (−2.9 to 2.5) | 0.10 (−3.3 to 3.8) | 0.005 |
Male, n (%) | 2888 (35.4) | 1861 (32.7) | 1027 (41.5) | <0.001 |
BMI, kg/m2 | 25.8 (23.6–28.1) | 25.8 (23.6–28.0) | 25.9 (23.6–28.2) | 0.308 |
WC, cm | 82 (77–88) | 82 (76–87) | 84 (79–90) | <0.001 |
Current smoking, n (%) | 1551 (19.0) | 1197 (21.0) | 354 (14.3) | <0.001 |
SBP, mmHg | 131.3 (121.3–143.0) | 128.7 (119.7–139.7) | 137.7 (127.7–149.7) | <0.001 |
DBP, mmHg | 74.3 (68.0–81.0) | 75.3 (69.0–82.0) | 72.0 (65.3–79.0) | <0.001 |
Heart rate, bpm | 77.7 (70.7–85.0) | 77.3 (70.7–84.7) | 78.0 (70.6–85.7) | 0.11 |
TC, mmol/L | 5.3 (4.7–5.9) | 5.3 (4.7–5.9) | 5.3 (4.6–6.0) | 0.929 |
TG, mmol/L | 1.3 (0.9–1.9) | 1.3 (0.9–1.9) | 1.3 (1.0–1.8) | 0.378 |
HDL-C, mmol/L | 1.4 (1.2–1.7) | 1.4 (1.2–1.7) | 1.4 (1.2–1.7) | 0.839 |
LDL-C, mmol/L | 3.2 (2.7–3.8) | 3.2 (2.7–3.8) | 3.3 (2.7–3.8) | 0.186 |
FBG, mmol/L | 5.6 (5.2–6.3) | 5.6 (5.2–6.2) | 5.8 (5.4–6.7) | <0.001 |
eGFR, mL/min/1.73 m2 | 97.4 (88.1–103.7) | 101.0 (95.0–105.8) | 87.6 (77.7–93.8) | <0.001 |
Hypertension, n (%) | 3872 (47.4) | 2236 (39.3) | 1636 (66.2) | <0.001 |
Diabetes, n (%) | 1930 (23.6) | 1091 (19.2) | 839 (33.9) | <0.001 |
Dyslipidemia, n (%) | 5790 (70.9) | 3965 (69.7) | 1825 (73.8) | <0.001 |
Anti-hypertensive medications, n (%) | 2415 (29.6) | 1312 (23.1) | 1103 (44.6) | <0.001 |
Anti-diabetes medications, n (%) | 794 (9.7) | 416 (7.3) | 378 (15.3) | <0.001 |
Lipid-lowering medications, n (%) | 725 (8.9) | 398 (7.0) | 327 (13.2) | <0.001 |
CVD risk, % | 5.2 (2.6–10.3) | 3.6 (2.0–6.7) | 11.4 (7.2–17.2) | <0.001 |
baPWV, m/s | 15.7 (13.9–18.2) | 14.9 (13.4–16.8) | 18.4 (16.1–21.2) | <0.001 |